ENOV
Price
$31.17
Change
+$0.18 (+0.58%)
Updated
Aug 26 closing price
Capitalization
1.78B
64 days until earnings call
ZBH
Price
$107.54
Change
+$0.22 (+0.20%)
Updated
Aug 26 closing price
Capitalization
21.3B
63 days until earnings call
Interact to see
Advertisement

ENOV vs ZBH

Header iconENOV vs ZBH Comparison
Open Charts ENOV vs ZBHBanner chart's image
Enovis
Price$31.17
Change+$0.18 (+0.58%)
Volume$1.19M
Capitalization1.78B
Zimmer Biomet Holdings
Price$107.54
Change+$0.22 (+0.20%)
Volume$1.79M
Capitalization21.3B
ENOV vs ZBH Comparison Chart in %
Loading...
ENOV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZBH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ENOV vs. ZBH commentary
Aug 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ENOV is a StrongBuy and ZBH is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 27, 2025
Stock price -- (ENOV: $31.17 vs. ZBH: $107.54)
Brand notoriety: ENOV and ZBH are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: ENOV: 79% vs. ZBH: 101%
Market capitalization -- ENOV: $1.78B vs. ZBH: $21.3B
ENOV [@Medical/Nursing Services] is valued at $1.78B. ZBH’s [@Medical/Nursing Services] market capitalization is $21.3B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $229.03B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ENOV’s FA Score shows that 0 FA rating(s) are green whileZBH’s FA Score has 1 green FA rating(s).

  • ENOV’s FA Score: 0 green, 5 red.
  • ZBH’s FA Score: 1 green, 4 red.
According to our system of comparison, ZBH is a better buy in the long-term than ENOV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ENOV’s TA Score shows that 5 TA indicator(s) are bullish while ZBH’s TA Score has 5 bullish TA indicator(s).

  • ENOV’s TA Score: 5 bullish, 4 bearish.
  • ZBH’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both ENOV and ZBH are a good buy in the short-term.

Price Growth

ENOV (@Medical/Nursing Services) experienced а +2.40% price change this week, while ZBH (@Medical/Nursing Services) price change was +3.10% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +3.83%. For the same industry, the average monthly price growth was +2.90%, and the average quarterly price growth was +9.85%.

Reported Earning Dates

ENOV is expected to report earnings on Oct 30, 2025.

ZBH is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Medical/Nursing Services (+3.83% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ZBH($21.3B) has a higher market cap than ENOV($1.78B). ZBH YTD gains are higher at: 2.291 vs. ENOV (-28.965). ZBH has higher annual earnings (EBITDA): 2.28B vs. ENOV (-472.1M). ZBH has more cash in the bank: 557M vs. ENOV (44.1M). ENOV has less debt than ZBH: ENOV (1.47B) vs ZBH (7.57B). ZBH has higher revenues than ENOV: ZBH (7.83B) vs ENOV (2.19B).
ENOVZBHENOV / ZBH
Capitalization1.78B21.3B8%
EBITDA-472.1M2.28B-21%
Gain YTD-28.9652.291-1,264%
P/E RatioN/A26.23-
Revenue2.19B7.83B28%
Total Cash44.1M557M8%
Total Debt1.47B7.57B19%
FUNDAMENTALS RATINGS
ENOV vs ZBH: Fundamental Ratings
ENOV
ZBH
OUTLOOK RATING
1..100
715
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
21
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9680
PRICE GROWTH RATING
1..100
6048
P/E GROWTH RATING
1..100
9837
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ZBH's Valuation (21) in the Medical Specialties industry is somewhat better than the same rating for ENOV (79) in the Industrial Machinery industry. This means that ZBH’s stock grew somewhat faster than ENOV’s over the last 12 months.

ZBH's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as ENOV (100) in the Industrial Machinery industry. This means that ZBH’s stock grew similarly to ENOV’s over the last 12 months.

ZBH's SMR Rating (80) in the Medical Specialties industry is in the same range as ENOV (96) in the Industrial Machinery industry. This means that ZBH’s stock grew similarly to ENOV’s over the last 12 months.

ZBH's Price Growth Rating (48) in the Medical Specialties industry is in the same range as ENOV (60) in the Industrial Machinery industry. This means that ZBH’s stock grew similarly to ENOV’s over the last 12 months.

ZBH's P/E Growth Rating (37) in the Medical Specialties industry is somewhat better than the same rating for ENOV (98) in the Industrial Machinery industry. This means that ZBH’s stock grew somewhat faster than ENOV’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ENOVZBH
RSI
ODDS (%)
Bullish Trend 2 days ago
55%
Bearish Trend 2 days ago
68%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
72%
Bearish Trend 2 days ago
61%
Momentum
ODDS (%)
Bullish Trend 2 days ago
64%
Bullish Trend 2 days ago
65%
MACD
ODDS (%)
Bullish Trend 2 days ago
68%
Bullish Trend 2 days ago
54%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
64%
Bullish Trend 2 days ago
59%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
63%
Bullish Trend 2 days ago
59%
Advances
ODDS (%)
Bullish Trend 14 days ago
60%
Bullish Trend 7 days ago
63%
Declines
ODDS (%)
Bearish Trend 6 days ago
75%
Bearish Trend 21 days ago
56%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 6 days ago
59%
Aroon
ODDS (%)
Bearish Trend 2 days ago
66%
Bullish Trend 2 days ago
55%
View a ticker or compare two or three
Interact to see
Advertisement
ENOV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZBH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
LFGY35.650.37
+1.05%
YieldMax Crypto Industry & Tech Portfolio Option Income ETF
ERET27.030.21
+0.78%
iShares Environmentally Aware Rl Est ETF
CARK42.340.22
+0.52%
CastleArk Large Growth ETF
PFIG24.140.03
+0.12%
Invesco Fdmtl Invmt Grd Corp Bd ETF
PFFA21.660.01
+0.05%
Virtus InfraCap US Preferred Stock ETF

ENOV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ENOV has been loosely correlated with IART. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if ENOV jumps, then IART could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENOV
1D Price
Change %
ENOV100%
+0.58%
IART - ENOV
59%
Loosely correlated
+3.43%
CNMD - ENOV
58%
Loosely correlated
+0.83%
FELE - ENOV
56%
Loosely correlated
+0.45%
DOV - ENOV
55%
Loosely correlated
+0.94%
ITGR - ENOV
54%
Loosely correlated
-0.30%
More

ZBH and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZBH has been loosely correlated with IART. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ZBH jumps, then IART could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZBH
1D Price
Change %
ZBH100%
+0.20%
IART - ZBH
48%
Loosely correlated
+3.43%
ENOV - ZBH
47%
Loosely correlated
+0.58%
HOLX - ZBH
43%
Loosely correlated
-0.74%
MDT - ZBH
41%
Loosely correlated
+0.15%
RVTY - ZBH
41%
Loosely correlated
-0.99%
More